CROASDALE; Rebecca
Patent Applications and Registrations
Patent applications and USPTO patent grants for CROASDALE; Rebecca.The latest application filed is for "activatable bispecific antibodies".
- CROASDALE; Rebecca - Antdorf DE
- Croasdale; Rebecca - Penzberg DE
| Patent | Date |
|---|---|
| Activatable Bispecific Antibodies App 20220017640 - BRINKMANN; Ulrich ; et al. | 2022-01-20 |
| Trivalent, Bispecific Antibodies App 20200062826 - BRINKMANN; Ulrich ; et al. | 2020-02-27 |
| Bispecific antibodies Grant 10,106,600 - Brinkmann , et al. October 23, 2 | 2018-10-23 |
| Trivalent, Bispecific Antibodies App 20180282399 - BRINKMANN; Ulrich ; et al. | 2018-10-04 |
| Trivalent, bispecific antibodies Grant 9,890,204 - Brinkmann , et al. February 13, 2 | 2018-02-13 |
| Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent Grant 9,574,016 - Brinkmann , et al. February 21, 2 | 2017-02-21 |
| Bispecific Her2 Antibodies And Methods Of Use App 20170029529 - Croasdale; Rebecca ; et al. | 2017-02-02 |
| Multispecific antibodies comprising full length antibodies and single chain fab fragments Grant 9,382,323 - Brinkmann , et al. July 5, 2 | 2016-07-05 |
| Complex Of Bi-specific Antibody And Digoxigenin Conjugated To A Therapeutic Or Diagnostic Agent App 20160009823 - Brinkmann; Ulrich ; et al. | 2016-01-14 |
| Bi-specific digoxigenin binding antibodies Grant 9,050,375 - Bramlage , et al. June 9, 2 | 2015-06-09 |
| Tri- Or Tetraspecific Antibodies App 20150030598 - CROASDALE; Rebecca ; et al. | 2015-01-29 |
| Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent Grant 8,907,069 - Brinkmann , et al. December 9, 2 | 2014-12-09 |
| Tri- or tetraspecific antibodies Grant 8,796,424 - Croasdale , et al. August 5, 2 | 2014-08-05 |
| Activatable Bispecific Antibodies App 20130266568 - BRINKMANN; ULRICH ; et al. | 2013-10-10 |
| Trivalent, Bispecific Antibodies App 20130022601 - Brinkmann; Ulrich ; et al. | 2013-01-24 |
| Bi-specific Digoxigenin Binding Antibodies App 20120282280 - Bramlage; Birgit ; et al. | 2012-11-08 |
| Complex Of Bi-specific Antibody And Digoxigenin Conjugated To A Therapeutic Or Diagnostic Agent App 20120269723 - Brinkmann; Ulrich ; et al. | 2012-10-25 |
| Bispecific Anti-egfr/anti-igf-1r Antibodies App 20120149879 - Brinkmann; Ulrich ; et al. | 2012-06-14 |
| Bispecific Antibodies App 20110293613 - BRINKMANN; ULRICH ; et al. | 2011-12-01 |
| Tri- or Tetraspecific Antibodies App 20100322935 - CROASDALE; REBECCA ; et al. | 2010-12-23 |
| Trivalent, Bispecific Antibodies App 20100256340 - Brinkmann; Ulrich ; et al. | 2010-10-07 |
| Multispecific Antibodies Comprising Full Length Antibodies And Single Chain Fab Fragments App 20100256338 - Brinkmann; Ulrich ; et al. | 2010-10-07 |
| Bispecific Anti-egfr/anti-igf-1r Antibodies App 20100081796 - Brinkmann; Ulrich ; et al. | 2010-04-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 